description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCGGAGAAACAGGACAACATTCAACAGCAGCCAACTGCAGGCCTTGGAGCGTGTCTTTGAGCGGACACATTACCCGGATGCTTTTGTTCGAGAAGATCTCGCACGTCGGGTGAACCTCACTGAGGCCAGAGTGCAGGTGTGGTTTCAGAACCGAAGAGCCAAGTTCCGCAGGAATGAGCGAGCCATGCTGGCCAATAAAAACGCTTCTCTCCTCAAGTCCTACTCAGGAGACGTGACTGCTGTGGAGCAACCCATCGTACCTCGTCCTGCTCCCAGACCAACCGATTATCTCTCCTGGGGGACAGCCTCTCCGTACAGCGCCATGGCTACTTATTCTGCCACATGTGCCAACAATAGCCCTGCACAGGGTATCAACATGGCCAACAGCATTGCCAACCTGAGACTGAAGGCCAAGGAATATAGTTTACAGAGGAACCAGGTGCC
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... PRRX1(18933), Prrx1(18933)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Sheng-Lin Xiong et al.
Molecular and cellular biochemistry, 389(1-2), 197-207 (2014-01-05)
High-density lipoprotein (HDL) has a significant cardioprotective effects. HDL induces cyclooxygenase-2 (COX-2) expression and prostacyclin I-2 (PGI-2) release in vascular endothelial cells, which contributes to its anti-atherogenic effects. However, the underlying mechanisms are not fully understood. In the present study
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU075641-50UG | 04061828295258 |
| EMU075641-20UG | 04061828524006 |